The Senator Paul
D. Wellstone Muscular Dystrophy Cooperative Research Center (MDCRC) is designed
to advance our abilities to treat the muscular dystrophies by capitalizing on
the breadth and depth of expertise at our collaborating institutions in the fields
of neuromuscular disease research and patient care, molecular genetics, immunology,
and gene therapy. The participating researchers include scientists and clinicians
from the University of Washington Medical Center, Children's Hospital and Regional
Medical Center, Fred Hutchinson Cancer Research Center and the VA Medical Center
in Seattle, Washington.
The MDCRC's goals are to provide an interactive
environment that will advance knowledge of and treatments for the muscular dystrophies
by promoting collaborations, providing shared resources, advancing basic research,
stimulating translational research, fostering outreach activities, developing
greater patient awareness of basic and clinical research and enabling their participation
in clinical trials, and by facilitating the development of gene therapy for the
muscular dystrophies. Our Center is composed of four research projects and four
Core laboratories, and includes a membership of more than 30 faculty members in
the Seattle area with interests in neuromuscular disease research.
director and co-director are Jeffrey Chamberlain and Stephen Tapscott, researchers
with a long history of genetic and clinical studies of the muscular dystrophies.
More about the members of the Seattle Wellstone MDCRC